Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP (1548)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
21.7 22.5 24.5 24.85 23.9 Last
10173900 11802000 17127730 23183000 11182000 Volume
-4.62% +3.69% +8.89% +1.43% -3.82% Change
Financials ( HKD)
Sales 2017 1 069 M
EBIT 2017 289 M
Net income 2017 225 M
Finance 2017 1 017 M
Yield 2017 -
Sales 2018 1 350 M
EBIT 2018 261 M
Net income 2018 211 M
Finance 2018 1 189 M
Yield 2018 -
P/E ratio 2017 169,86
P/E ratio 2018 195,10
EV / Sales2017 37,9x
EV / Sales2018 29,9x
Capitalization 41 546 M
More Financials
Company
Genscript Biotech Corp. engages in the provision of biological research service.It operates through the following segments: Life Science Research Services, Preclinical Drug Development Services, Life Sciences Research Catalog Products, and Industrial Synthetic Biology Products.The Life Science... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
01/12 GENSCRIPT BIOTECH : Bio completes US oligo pools business buy
01/04 GENSCRIPT BIOTECH : Acquires CustomArray to Expand Synthetic Biology Product Por..
01/03 GENSCRIPT BIOTECH : Bio inks consigned technology development deal
2017 GENSCRIPT BIOTECH : Bio to buy US oligo pools business
2017 GENSCRIPT BIOTECH : Legend Biotech Announces Closing of Global Strategic LCAR-B3..
2017 GENSCRIPT BIOTECH : Chinese biotech firm Genscripts shares jump by a third on US..
2017 GENSCRIPT BIOTECH : Bio in collaboration & license deal with Janssen
2017 JOHNSON & JOHNSON : Janssen, Legend partner for BCMA CAR T
2017 GENSCRIPT BIOTECH : Bio announces change in shareholding
2017 GENSCRIPT BIOTECH : Bio co-developed drug approved for clinical trial
More news
Sector news : Bio Diagnostics & Testing
10:36a European shares trade sideways, focus on M&A
10:27a Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
10:27a Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
09:20a BIOVERATIV : Sanofi shares fall on $11.6 billion Bioverativ takeover
08:48a SANOFI : Nears Deal for Bioverativ -- WSJ
More sector news : Bio Diagnostics & Testing
Latest Tweets
2017BRIEF-Genscript Biotech Says US, Ireland Units ?& Janssen Biotech Enter C.. 
2017Genscript Biotech soars 20 per cent after cancer drug wins go-ahead for clini.. 
More tweets
Qtime:4
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | 1548 | KYG3825B1059 | 4-Traders
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 21,8  HKD
Spread / Average Target -8,6%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang Chief Operating Officer & Executive Director
Jian Ge Meng Executive Director & Vice President-Finance
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP16.87%5 293
MIRACA HOLDINGS INC.-0.51%2 522
BEIJING STRONG BIOTECHNOLOGIES INC--.--%1 192
SEEGENE INC--.--%901
IOVANCE BIOTHERAPEUTICS INC33.75%777
INVITAE CORP--.--%378